Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long-term remission.

3D illustration of a person holding their knee. Red mono tone highlight at knee indicating joint pain

The study, published in Nature Medicine found that people with arthritis in long-term remission had a difference in cell function which could settle inflammation and 'teach' nearby cells to repair the joint.

Although treatment for rheumatoid arthritis has improved, some people with the condition do not respond well with many having unpredictable 'flare-ups' of the disease. Scientists now hope that by harnessing the benefit of these 'resolving' cells it could lead to new and more effective treatments.

The full story is available on the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences website

Similar stories

Oxford University academics recognised in Queen’s Birthday Honours

The pioneering work of members of the University, including research into tackling the Coronavirus pandemic, has been recognised in The Queen's Birthday Honours List.

Two Oxford Professors elected as EMBO Members

Professor Robert Klose and Professor Ervin Fodor are two of 64 life scientists to be elected to The European Molecular Biology Organization (EMBO).

Scientists make DNA breakthrough which could identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine at Oxford University have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

AI endoscopy enables 3D surface measurements of pre-cancerous condition in oesophagus

Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.

The COVID-19 International Modelling Consortium (CoMo Consortium) enters a new phase

Created in March 2020 to assist policymakers to make use of existing evidence in mathematical and epidemiological models to inform strategies for minimising the impact of COVID-19, the CoMo Consortium brings together mathematical modellers, epidemiologists, health economists and public health experts from more than 40 countries across Africa, Asia and South and North America.

New Head of the Department of Psychiatry – Professor Belinda Lennox

Professor Belinda Lennox has been welcomed to the role of Head of the Department of Psychiatry at the University of Oxford and will take over leadership in October 2021.